Table 1.
A comparison of symptom duration (weeks) with patient and tumour-related factors for the non-metastatic cases
| Group | Number | Mean | Range | Mean difference | 95% CI |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 564 | 76.7 | 1–1,040 | ||
| Female | 785 | 65.9 | 1–1,560 | 10.8 | −24.8–3.2 |
| Depth | |||||
| Subcutaneous | 309 | 98.1 | 2–1,300 | ||
| Deep | 1,000 | 62.6 | 1–1,560 | 35.4 | 16.5–54.4 |
| Grade | |||||
| High | 626 | 45.8 | 1–1,040 | High, intermediate 29.6 | 8.9–50.3 |
| Intermediate | 322 | 75.4 | 2–1,300 | High, low 61.4 | 39.8–83.0 |
| Low | 283 | 107.2 | 2–1,560 | Intermediate, low 31.8 | 7.2–56.4 |
| Histology | |||||
| Epithelioid/synovial | 149 | 125.4 | 1–1,040 | ||
| All others | 1,200 | 65.6 | 1–1,560 | 59.8 | 29.9–89.8 |